Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
1598 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.100 | 1.000 | 14 | 2009 | 2019 | ||||||
Colorectal Carcinoma
|
1186 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.060 | 0.833 | 6 | 2008 | 2017 | ||||||
Coronary Artery Disease
|
1022 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.060 | 0.833 | 6 | 2011 | 2019 | ||||||
Gestational Diabetes
|
206 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.060 | 1.000 | 6 | 2010 | 2019 | ||||||
Metabolic Syndrome X
|
477 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.060 | 1.000 | 6 | 2010 | 2017 | ||||||
Obesity
|
900 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.050 | 1.000 | 5 | 2013 | 2020 | ||||||
Hypertensive disease
|
871 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.040 | 1.000 | 4 | 2010 | 2017 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.040 | 0.750 | 4 | 2008 | 2017 | ||||||
Malignant Neoplasms
|
1441 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.040 | 0.500 | 4 | 2013 | 2017 | ||||||
Non-alcoholic Fatty Liver Disease
|
189 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.040 | 1.000 | 4 | 2015 | 2020 | ||||||
Primary malignant neoplasm
|
1374 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.040 | 0.500 | 4 | 2013 | 2017 | ||||||
Cardiovascular Diseases
|
382 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.030 | 0.333 | 3 | 2011 | 2018 | ||||||
Diabetic Nephropathy
|
208 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.030 | 1.000 | 3 | 2010 | 2015 | ||||||
Ischemic stroke
|
586 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.030 | 0.667 | 3 | 2006 | 2015 | ||||||
Breast Carcinoma
|
2145 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2011 | 2019 | ||||||
Coronary Arteriosclerosis
|
440 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2011 | 2011 | ||||||
Coronary heart disease
|
769 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2011 | 2012 | ||||||
Diabetes Mellitus
|
714 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2009 | 2015 | ||||||
Malignant neoplasm of breast
|
2154 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2011 | 2019 | ||||||
Alzheimer Disease, Late Onset
|
243 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Cerebral Infarction
|
123 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Colon Carcinoma
|
275 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
203 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Diabetes
|
611 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Diabetes Mellitus, Insulin-Dependent
|
388 | 0.637 | 0.560 | 3 | 186841685 | upstream gene variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 |